Scholars Central

Review articlePublished 29 Jul 2019

The Potential Benefits of PTH Analogs in Prevention of Pathological Fractures in Cerebral Palsy

Authors: Patrisha Shelley, Linda Edwards, Rafik Jacob

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Osteoporosis is a detrimental disorder of bone that puts patients at increased risk of pathologic fractures. Patients with cerebral palsy (CP), due to a multitude of factors, are at increased risk of developing this disorder. Studies in the past have looked at various treatment options for these patients to reduce and/or prevent pathologic fractures. Most studies have looked into the use of bisphosphonates for prevention. Teriparatide is a recombinant PTH analog that has been shown to increase bone mineral density and reduce fragility fractures in adults with non- CP related osteoporosis. Despite the reduction seen in these studies, empirical evidence for the use of PTH analogs in CP related osteoporosis is scarce. PTH analogs, like Teriparatide, have shown to be beneficial in patients with non-CP related osteoporosis, further studies need to be performed to assess its benefit for patients with CP related osteoporosis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Childhood & Developmental Disorders.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Childhood & Developmental Disorders
  • SubjectPaediatrics & Neonatology
  • BylineArticles whose byline prints “Patrisha Shelley”
  • BylineArticles whose byline prints “Linda Edwards”
  • BylineArticles whose byline prints “Rafik Jacob”